Results from multiple phase 3 clinical trails have led to the FDA approval of upadacitinib to treat patients with moderate to severe active RA…
Rituximab-Induced Serum Sickness Is More Frequent in Autoimmune Diseases
Recent research into rituximab-induced serum sickness (RISS) reinforces the understanding that patients generally recover quickly. However, the study also found patients with autoimmune disease, especially SLE, had a significantly higher risk for developing RISS than patients using rituximab to treat hematological malignancy…
Practice Matters: New Workshop Will Provide Insights into Practice Management at the 2019 ACR/ARP Annual Meeting
Technology, billing, regulations—how do rheumatologists manage the business side of their practices in an ever-changing environment? During this year’s Annual Meeting, a practical, full-day workshop will offer attendees the tools to thrive in today’s healthcare business landscape…
Intensive, Personalized Learning
During the 2019 ACR/ARP Annual Meeting, the new Meet the Professor Workshops and sessions will feature hands-on training on state-of-the-art topics…
Give Them Time: 3 Tips for Using Time with Patients to Aid Shared Decision Making
Arwen Pieterse, PhD, and colleagues urge all physicians to allocate more meaningful time to collaborate in shared decision making with patients, without compromising access or productivity…
Autologous Serum Tears Receives High Patient Satisfaction Scores for Dry Eye Disease
Although not a first-line treatment, autologous serum tears are often used as a treatment option for dry eyes related to both ophthalmic and rheumatic conditions. Recent research into its efficacy also evaluated the treatment’s patient satisfaction, finding autologous serum tears reduced symptoms of dry eye disease and received high patient satisfaction scores…
Long-Term Physical Activity Lowers the Risk of RA among Women
A new study adds to the evidence that metabolic factors play an important role in the pathogenesis of rheumatoid arthritis (RA). In this large, prospective cohort study, Liu et al. found that increased physical activity among women was associated with a reduced risk of RA…
Filgotinib Promising for RA
Research shows filgotinib may be safe and effective for treating rheumatoid arthritis. The drug’s manufacturer is expected to be submit a new drug application for filgotinib to the FDA in 2019…
Osteoporosis Drugs Don’t Reduce Overall Mortality
NEW YORK (Reuters Health)—Anti-fracture medications do not reduce overall mortality in older patients with osteoporosis, according to an updated systematic review and meta-analysis. “This meta-analysis suggests drug treatments, including treatment with bisphosphonates, for osteoporosis should be recommended only for the prevention of fracture and not for any additional reduction in mortality,” researchers write in JAMA…
Trump Administration to Appeal Ruling Blocking Price Disclosure for Drug Ads
(Reuters)—The Trump administration is appealing a court ruling that struck down its plan to compel pharmaceutical companies to disclose wholesale prices of their drugs in televisions advertisements. The U.S. Department of Health and Human Services (HHS) filed a notice of appeal on Wednesday, as it prepares to challenge the July federal court ruling. “If the…
- « Previous Page
- 1
- …
- 247
- 248
- 249
- 250
- 251
- …
- 818
- Next Page »